Search results

Researchers from La Trobe University have used the Australian Synchrotron to help identify a key mechanism in how SARS-CoV-2 damages lung tissue.

The instrument is very well suited for the study of kinetic effects, like relaxation following a chemical reaction, or external impulses like mechanical deformation, an electric or magnetic field.

A new imaging technology developed at ANSTO makes it possible to image, identify and locate gamma-ray radiation in a safe and timely manner.

ANSTO's OPAL reactor is one of the world's most advanced and reliable research reactors today. To ensure we can continue operating OPAL safely and reliably and maximise utilisation, ANSTO must regularly carry out maintenance and upgrades.

Today The Australian ran a story entitled “Fears for indigenous lands as foreign nuclear waste headed our way”, 18 September 2018. ANSTO was not contacted in relation to the article, but can provide the following information in response which can be attributed to a spokesperson.

ANSTO's unique capabilities are being used to develop a quick analytical tool to determine the geographic origin of seafood and authenticates quality.

ANSTO undertakes a rigorous environmental monitoring program and shares expertise nationally and internationally.

International interest is building in Australia’s new multi-million-dollar radioactive waste processing facility at the Sydney campus of the Australian Nuclear Science and Technology Organisation (ANSTO).

General manager ANSTO Communications and Stakeholder Engagement was one of the presenters at the IAEA W4NSEC workshop

This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.

ANSTO is interested finding students to collaborate on Generation IV reactor systems.

Australia’s new state-of-the-art nuclear medicine facility gets green light.

CORIS360® GNI images gamma-ray and thermal neutron radiation sources, delivering an unprecedented ability to detect, localise, and identify nuclear materials.

The Australian Nuclear Science and Technology Organisation (ANSTO) has joined a team, lead by the US Department of Energy’s Pacific Northwest National Laboratory (PNNL), to install a high resolution monitoring system at ANSTO’s medical isotope production facility in Lucas Heights, Australia.

Insights into the crystallisation process of twin crystals important for drug production.